CBIO
NASDAQ · Biotechnology
Crescent Biopharma Inc
$18.76
+0.76 (+4.22%)
Open$18.08
Previous Close$18.00
Day High$19.53
Day Low$17.99
52W High$28.00
52W Low$8.72
Volume—
Avg Volume309.1K
Market Cap510.91M
P/E Ratio—
EPS$-15.11
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+47.4% upside
Current
$18.76
$18.76
Target
$27.66
$27.66
$15.31
$27.66 avg
$30.74
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 28.80M | 57.99M | 51.60M |
| Net Income | -414,225,474 | 180.8K | 210.8K |
| Profit Margin | -1,438.1% | 0.3% | 0.4% |
| EBITDA | -405,210,590 | 390.2K | 358.0K |
| Free Cash Flow | — | 84.1K | 101.4K |
| Rev Growth | +413.7% | +8.6% | +24.1% |
| Debt/Equity | — | 0.52 | 0.47 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |